Saxonov Serge 4
4 · 10x Genomics, Inc. · Filed Dec 23, 2024
Insider Transaction Report
Form 4
Saxonov Serge
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2024-12-23$1.20/sh+12,000$14,400→ 884,574 total - Exercise/Conversion
Stock Option (right to buy)
2024-12-23−12,000→ 67,463 totalExercise: $1.20Exp: 2027-10-18→ Class A Common Stock (12,000 underlying)
Holdings
- 22,570(indirect: See footnote)
Class A Common Stock
- 27(indirect: See footnote)
Class A Common Stock
- 870(indirect: See footnote)
Class A Common Stock
- 213,250(indirect: See footnote)
Class A Common Stock
Footnotes (5)
- [F1]The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
- [F2]The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
- [F3]The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
- [F4]The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.
- [F5]This option, originally for 300,000 shares, of which 232,537 have been exercised, vested as to 1/48th of the shares on October 1, 2017, and was fully vested as of October 1, 2021.